Fewer Annual Deaths in Japan with Negative Excess Mortality for COVID-19

Bando, Hiroshi

doi:10.36502/2021/asjbccr.6234

Asp Biomed Clin Case Rep

2021

DOI: 10.36502/2021/asjbccr.6234

|View full text |Cite

Fewer Annual Deaths in Japan with Negative Excess Mortality for COVID-19

Hiroshi Bando

Abstract: The excess mortality would be adequate objective indicator for COVID-19 research, and was reported in 77 countries for 2020. Several representative data are: United States 420,000, Mexico 270,000, Russia 270,000, Brazil 170,000, Japan -15,000, Taiwan -4,800, Australia -4,700 and New Zealand -2,100. From demographics in Japan, the number of deaths increased by 18 thousand each year during 2015-2019. However, death in 2020 decreased by 9,373 from 2019, which indicated 27 thousand difference. A meaningful perspec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2023

Publication Types

Select...

Article4

Relationship

Self Cite3

Independent1

Authors

Journals

Cited by 4 publications

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Estimating excess mortalities due to the COVID-19 pandemic in Malaysia between January 2020 and September 2021

Jayaraj

Chong

Wan

et al. 2023

Sci Rep

View full text Add to dashboard Cite

Excess mortalities are a more accurate indicator of true COVID-19 disease burden. This study aims to investigate levels of excess all-cause mortality and their geographic, age and sex distributions between January 2020-September 2021. National mortality data between January 2016 and September 2021 from the Department of Statistics Malaysia was utilised. Baseline mortality was estimated using the Farrington algorithm and data between 1 January 2016 and 31 December 2019. The occurrence of excess all-cause mortality by geographic-, age- and sex-stratum was examined from 1 January 2020 to 30 September 2021. A sub-analysis was also conducted for road-traffic accidents, ethnicity and nationality. Malaysia had a 5.5–23.7% reduction in all-cause mortality across 2020. A reversal is observed in 2021, with an excess of 13.0–24.0%. Excess mortality density is highest between July and September 2021. All states and sexes reported excess trends consistent with the national trends. There were reductions in all all-cause mortalities in individuals under the age of 15 (0.4–8.1%) and road traffic accident-related mortalities (36.6–80.5%). These reductions were higher during the first Movement Control Order in 2020. Overall, there appears to be a reduction in all-cause mortality for Malaysia in 2020. This trend is reversed in 2021, with excess mortalities being observed. Surveillance of excess mortalities can allow expedient detection of aberrant events allowing timely health system and public health responses.

show abstract

Estimating excess mortalities due to the COVID-19 pandemic in Malaysia between January 2020 and September 2021

Jayaraj

Chong

Wan

et al. 2023

Sci Rep

View full text Add to dashboard Cite

show abstract

Some Measures for COVID-19 Including Deep Ultraviolet Light-Emitting Diode (DUV-LED), Gc protein-derived Macrophage-Activating Factor (Gcmaf), and 5-Aminolevulinic Acid (5-ALA)

Bando

2021

Asp Biomed Clin Case Rep

Self Cite

View full text Add to dashboard Cite

Several trials for the COVID-19 pandemic are found. Prof. Shunji Nakamura, Tokushima University was awarded the 2014 Nobel prize in Physics for light-emitting diodes (LEDs). Deep ultraviolet LED (DUV-LED) causes SARS-CoV-2 inactivation as 99.9% by 265 nm. Gc protein-derived macrophage-activating factor (GcMAF)-based immunotherapy has a wider application for serious infection, chronic fatigue syndrome, and cancers. Covid center in Naples submitted a phase II report concerning GcMAF and COVID-19 in Feb 2021. 5-aminolevulinic acid (5-ALA) and its metabolite protoporphyrin IX (PpIX) show anti-inflammatory and antiviral effects for Zika, Dengue, influenza A viruses, and SARS-CoV-2. These results hopefully contribute to the research development for COVID-19.

show abstract

Current Data on Lower Prevalence and Age-Related Aggravation of COVID-19 in Japan

Bando

2021

Asp Biomed Clin Case Rep

Self Cite

View full text Add to dashboard Cite

Pandemic COVID-19 has been crucial problem worldwide, and authors have reported less prevalence and excess death in Japan. The Ministry of Health, Labour and Welfare of Japan presented COVID-report of July 2021 Edition. Among them, the number of people diagnosed with COVID-19 in Japan was 796,835 until July 1, 2021, which is equivalent to 0.6% of the total population. Aggravation rate of COVID-19 increases remarkably with aging. The result shows 1, 4, 10, 25, 47, 70< in 30s, 40s, 50s, 60, 70s, 80s< years old, respectively. In contrast, it shows 0.5, 0.2, 0.3 in <9, 10-19, 20-29 years, respectively.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Fewer Annual Deaths in Japan with Negative Excess Mortality for COVID-19

Cited by 4 publications

References 16 publications

Estimating excess mortalities due to the COVID-19 pandemic in Malaysia between January 2020 and September 2021

Estimating excess mortalities due to the COVID-19 pandemic in Malaysia between January 2020 and September 2021

Some Measures for COVID-19 Including Deep Ultraviolet Light-Emitting Diode (DUV-LED), Gc protein-derived Macrophage-Activating Factor (Gcmaf), and 5-Aminolevulinic Acid (5-ALA)

Current Data on Lower Prevalence and Age-Related Aggravation of COVID-19 in Japan

Contact Info

Product

Resources

About